reports, 2-4 they showed decreased immunostaining for H þ -ATPase in the cortical collecting duct of the patient. The cause of the reduced expression of H þ -ATPase in intercalated cells (ICs) of dRTA kidneys in Sjögren's syndrome is unknown.
A 29-year-old woman with sicca syndrome presented with hypokalemia (2.4 mEq/l), hyperchloremic metabolic acidosis (plasma HCO 3 À 13 mEq/l), inappropriate urine (pH 7.0), positive urinary anion gap (þ 21 mEq/l), and normal renal function. She had polyclonal hypergammaglobulinemia, positive antinuclear antibodies and anti-Ro/SS-A, and inflammatory infiltrates in the parotid gland biopsy. On bicarbonate loading, FE HCO3À was o5%, with a low (urinary-blood) DpCO 2 (13 mm Hg), suggesting defective H þ secretion by A-type IC. The kidney biopsy revealed mild inflammatory cell infiltrates, without interstitial fibrosis. Compared with control kidneys, a strong attenuation of H þ -ATPase immunoreactivity was observed both in the proximal tubule and in the collecting duct profiles (Figure 1a and b). In particular, no ICs positive for H þ -ATPase were detectable, although ICs could be identified by electron microscopy (Figure 1c-f ). Importantly, the immunoglobulin G purified from the dRTA patient detected ICs in collecting duct profiles of human control kidneys (Figure 1g-k) .
These data reveal that patients with Sjögren's syndrome may present autoantibodies directed against the A-type IC of the human kidney. Identifying these antigens could improve our understanding of the role of IC cells and the pathophysiology of dRTA. 
